Vaxxa AB (XSAT:VAXXA) Piotroski F-Score: 4 (As of Jul. 30, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:VAXXA Vaxxa AB XSAT:VAXXA
25 GF Score
Price kr0.50
GF Value kr0.76
Valuation Significantly Undervalued
View Full Analysis

What is Vaxxa AB Piotroski F-Score?

Vaxxa AB XSAT:VAXXA +14.22% 25 Piotroski F-Score is 4 as of Jul. 30, 2026, which is at its 10-year median of 4.00. GuruFocus rates XSAT:VAXXA with a GF Score™ of 25/100 and a GF Value™ of kr0.76 (Significantly Undervalued). Among 2,735 Software companies, Vaxxa AB ranks worse than 60.37% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Vaxxa AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Vaxxa AB's Piotroski F-Score or its related term are showing as below:

XSAT:VAXXA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 10 years, the highest Piotroski F-Score of Vaxxa AB was 6. The lowest was 2. And the median was 4.

Vaxxa AB  (XSAT:VAXXA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Vaxxa AB Piotroski F-Score Related Terms


Vaxxa AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB Piotroski F-Score Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 2.00 4.00 6.00 2.00

Vaxxa AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 2.00 2.00 4.00

XSAT:VAXXA vs QH, SHOP, UBER: Piotroski F-Score Comparison

For the Software - Application subindustry, Vaxxa AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxa AB Piotroski F-Score vs Software Industry

For the Software industry and Technology sector, Vaxxa AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Vaxxa AB's Piotroski F-Score falls into.


XSAT:VAXXA
25GF Score
Vaxxa AB XSAT:VAXXA
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was -0.489 + -1.371 + -1.697 + 0.002 = kr-3.56 Mil.
Cash Flow from Operations was -1.721 + 0 + -1.618 + 1.679 = kr-1.66 Mil.
Revenue was 21.123 + 22.851 + 17.942 + 29.491 = kr91.41 Mil.
Gross Profit was 2.526 + 2.259 + 1.458 + 3.517 = kr9.76 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(24.127 + 23.765 + 22.137 + 26.02 + 26.13) / 5 = kr24.4358 Mil.
Total Assets at the begining of this year (Jun25) was kr24.13 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr14.63 Mil.
Total Current Liabilities was kr12.68 Mil.
Net Income was 0.007 + -0.602 + -0.682 + -1.6 = kr-2.88 Mil.

Revenue was 21.349 + 16.842 + 12.248 + 18.847 = kr69.29 Mil.
Gross Profit was 2.412 + 1.174 + 1.935 + 1.816 = kr7.34 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(22.454 + 24.112 + 27.821 + 36.69 + 24.127) / 5 = kr27.0408 Mil.
Total Assets at the begining of last year (Jun24) was kr22.45 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr11.95 Mil.
Total Current Liabilities was kr1.75 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Vaxxa AB's current Net Income (TTM) was -3.56. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Vaxxa AB's current Cash Flow from Operations (TTM) was -1.66. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=-3.555/24.127
=-0.1473453

ROA (Last Year)=Net Income/Total Assets (Jun24)
=-2.877/22.454
=-0.12812862

Vaxxa AB's return on assets of this year was -0.1473453. Vaxxa AB's return on assets of last year was -0.12812862. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Vaxxa AB's current Net Income (TTM) was -3.56. Vaxxa AB's current Cash Flow from Operations (TTM) was -1.66. ==> -1.66 > -3.56 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=0/24.4358
=0

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=0/27.0408
=0

Vaxxa AB's gearing of this year was 0. Vaxxa AB's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=14.626/12.679
=1.15356101

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=11.945/1.75
=6.82571429

Vaxxa AB's current ratio of this year was 1.15356101. Vaxxa AB's current ratio of last year was 6.82571429. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Vaxxa AB's number of shares in issue this year was 43.367. Vaxxa AB's number of shares in issue last year was 43.243. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=9.76/91.407
=0.10677519

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=7.337/69.286
=0.10589441

Vaxxa AB's gross margin of this year was 0.10677519. Vaxxa AB's gross margin of last year was 0.10589441. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=91.407/24.127
=3.78857711

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=69.286/22.454
=3.08568629

Vaxxa AB's asset turnover of this year was 3.78857711. Vaxxa AB's asset turnover of last year was 3.08568629. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Vaxxa AB has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Vaxxa AB (XSAT:VAXXA) has a Piotroski F-Score of 4 as of Jul. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Vaxxa AB and its competitors. This is near median its historical median of 4.00. Over the past decade, Vaxxa AB's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, Vaxxa AB ranks #1651 out of 2735 companies in the Software industry, placing it in the top 60.4%.
Is Vaxxa AB's Piotroski F-Score too high?
Vaxxa AB's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Software industry median Piotroski F-Score is 5.00. Vaxxa AB's value of 4 is 20% below this industry median. Based on the distribution chart, Vaxxa AB ranks #1651 out of 2735 companies in the Software industry, which is below the industry midpoint. Overall, Vaxxa AB has a GF Score™ of 25/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's Piotroski F-Score compare to QH and SHOP?
According to the Software industry distribution chart, Vaxxa AB ranks #1651 out of 2735 companies for Piotroski F-Score. This places Vaxxa AB in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Vaxxa AB's value of 4 is 20% below this benchmark. Historically, Vaxxa AB's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Vaxxa AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Software company?
The median Piotroski F-Score among Software companies is 5.00, based on 2,735 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaxxa AB's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Vaxxa AB and its competitors. For the Software industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Based on GuruFocus' analysis, Vaxxa AB (XSAT:VAXXA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.76, compared to a current price of kr0.50 — trading 34.5% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Software industry median of 5.00. Vaxxa AB's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Vaxxa AB (XSAT:VAXXA), the current Piotroski F-Score is 4 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (XSAT:VAXXA) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of kr0.50 is trading 34.5% below its estimated GF Value™ of kr0.76. GuruFocus considers Vaxxa AB to be Significantly Undervalued.

Key valuation signals for XSAT:VAXXA:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: kr0.76 vs. price of kr0.50 (34.5% below fair value)
  • GF Score™: 25/100
  • Industry Position: 20% below the Software median (#1651 of 2735)

No single metric tells the full story. See the XSAT:VAXXA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxxa AB Business Description

Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
25GF Score

Get the complete analysis for XSAT:VAXXA

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.50
Price
kr0.76
GF Value